Advertisement

Related Videos

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Opportunities to Optimize Cancer Policies Panel Discussion

Peter Clark, MA, MD, FRCP: A Payer Perspective

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Advertisement

Advertisement




May
21
Today In Oncology
Short-Term Fasting Around Chemotherapy May Improve Treatment Response in Ovarian Cancer
Yoga Intervention May Reduce Mood Disturbance, Anxiety, Fatigue, and Insomnia in Cancer Survivors
Cognitive Effects of Darolutamide vs Enzalutamide in Advanced Prostate Cancer
GLP-1 RAs May Reduce Metastatic Progression in Certain Obesity-Related Cancers
Early-Stage Breast Cancer: Losing Weight, Gaining Quality of Life
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo